HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$30.88
Day range
$29.25 - $31.49
Year range
$12.91 - $42.13
Market cap
2.73B USD
Avg Volume
2.43M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 129.69M | 73.41% |
Operating expense | 101.69M | 46.32% |
Net income | 2.73M | 104.53% |
Net profit margin | 2.10 | 102.61% |
Earnings per share | 0.37 | 178.72% |
EBITDA | -14.29M | 69.75% |
Effective tax rate | -4.37% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 322.80M | -12.92% |
Total assets | 605.19M | 1.86% |
Total liabilities | 490.36M | -8.35% |
Total equity | 114.83M | — |
Shares outstanding | 92.24M | — |
Price to book | 24.51 | — |
Return on assets | -14.18% | — |
Return on capital | -19.15% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.73M | 104.53% |
Cash from operations | 60.68M | 269.87% |
Cash from investing | -104.84M | -30.54% |
Cash from financing | 26.68M | -80.82% |
Net change in cash | -17.90M | -180.88% |
Free cash flow | 17.18M | 226.76% |
About
Founded
2008
Website
Employees
497
